Donald Zuhn

Donald Zuhn

McDonnell Boehnen Hulbert & Berghoff LLP

Contact  |  View Bio  |  RSS

Latest Posts › Patent-Eligible Subject Matter

Share:

Sequenom Requests Rehearing En Banc

Earlier this summer, in Ariosa Diagnostics, Inc. v. Sequenom, Inc., the Federal Circuit affirmed a decision by the District Court for the Northern District of California granting summary judgment of invalidity of the asserted...more

8/19/2015 - Method Claims Myriad-Mayo Patent Invalidity Patent-Eligible Subject Matter Patents Petition For Rehearing Summary Judgment

Drew Hirshfeld Appointed as New Commissioner of Patents

The U.S. Patent and Trademark Office announced earlier today that U.S. Secretary of Commerce Penny Pritzker has appointed Deputy Commissioner for Patent Examination Policy Drew Hirshfeld to be the new Commissioner for Patents...more

7/31/2015 - Administrative Appointments America Invents Act First-to-File First-to-Invent Inventors Patent Examinations Patent-Eligible Subject Matter Policy Drafting Supplemental Examination USPTO

Koepsell and Noonan on Gene Patenting

In 2009, the first edition of Dr. David Koepsell's book "Who Owns You: The Corporate Gold Rush to Patent Your Genes" was published. With the second edition of his text about to be published, Dr. Koepsell allowed Patent Docs...more

5/29/2015 - BRCA DNA Gene Patenting Myriad Myriad-Mayo Patent-Eligible Subject Matter Patents

USPTO Holds Forum on Interim Guidance -- Part III

In a forum held last month on the U.S. Patent and Trademark Office's Alexandria campus, Office representatives discussed the Interim Guidance on Patent Subject Matter Eligibility, which was released in December, and received...more

2/20/2015 - CLS Bank v Alice Corp Covered Business Method Patents Life Sciences Patent-Eligible Subject Matter Patents Technology USPTO

USPTO Holds Forum on Interim Guidance -- Part II

In a forum held last month on the U.S. Patent and Trademark Office's Alexandria campus, Office representatives discussed the Interim Guidance on Patent Subject Matter Eligibility, which was released in December, and received...more

2/19/2015 - Interim Guidance Patent-Eligible Subject Matter Patents Public Comment USPTO

USPTO Holds Forum on Interim Guidance -- Part I

In a forum held January 21 on the U.S. Patent and Trademark Office's Alexandria campus, Office representatives discussed the Interim Guidance on Patent Subject Matter Eligibility, which was released in December, and received...more

2/4/2015 - Interim Guidance Myriad-Mayo Patent-Eligible Subject Matter Patents USPTO

Top Three Stories of 2014

After reflecting upon the events of the past twelve months, Patent Docs presents its eighth annual list oftop patent stories. For 2014, we identified eighteen stories that were covered on Patent Docs last year that we...more

1/8/2015 - America Invents Act AMP v Myriad CLS Bank v Alice Corp DNA Genetic Materials Mayo v. Prometheus Patent Litigation Patent-Eligible Subject Matter Patents Post-Grant Review USPTO

USPTO to Release Revised Subject Matter Eligibility Guidance

In a conference call this morning, Drew Hirshfeld, U.S. Patent and Trademark Office Deputy Commissioner for Patent Examination Policy, announced that the USPTO would be releasing revised guidance on subject matter eligibility...more

12/15/2014 - Mayo v. Prometheus Myriad Patent-Eligible Subject Matter Patents USPTO

Examination of Myriad-Mayo Guidance Comments -- The Coalition for 21st Century Medicine -- Part II

On March 4, the U.S. Patent and Trademark Office issued a guidance memorandum, entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural...more

12/3/2014 - Draft Guidance Genetic Materials Mayo v. Prometheus Myriad-Mayo Patent-Eligible Subject Matter Patents USPTO

Examination of Myriad-Mayo Guidance Comments -- The Coalition for 21st Century Medicine

On March 4, the U.S. Patent and Trademark Office issued a guidance memorandum, entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural...more

12/2/2014 - Draft Guidance Mayo v. Prometheus Myriad-Mayo Patent-Eligible Subject Matter Patents USPTO

BIO IPCC Panel Discusses Impact of Myriad-Mayo Guidance

Yesterday, we reported on a session of the Biotechnology Industry Organization (BIO) Intellectual Property Counsel's Committee fall conference, which took place earlier this week in Nashville, TN, in which the U.S. Patent and...more

11/14/2014 - Biotechnology Genetic Materials Guidance Update Myriad-Mayo Patent-Eligible Subject Matter Patents Pharmaceutical USPTO

USPTO Provides Update on Status of Revised Myriad-Mayo Guidance

During a session of the Biotechnology Industry Organization (BIO) Intellectual Property Counsels Committee (IPCC) fall conference, which took place this week in Nashville, TN, the U.S. Patent and Trademark Office provided a...more

11/13/2014 - Biotechnology Genetic Materials Guidance Update Myriad-Mayo Patent-Eligible Subject Matter Patents USPTO

Examination of Myriad-Mayo Guidance Comments -- BIO Joint Comment

On March 4, the U.S. Patent and Trademark Office issued a guidance memorandum, entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural...more

10/24/2014 - AMP v Myriad Biotechnology Draft Guidance Genetic Materials Mayo v. Prometheus Myriad-Mayo Patent-Eligible Subject Matter Patents Pharmaceutical Manufacturers Public Comment Trade Associations USPTO

Sherry Knowles Addresses Real World Impact of Myriad-Mayo Guidance at BIO Symposium

Last month, at the Biotechnology Industry Organization (BIO) IP & Diagnostics Symposium in Alexandria, VA, Sherry Knowles of Knowles IP Strategies addressed the impact of the U.S. Patent and Trademark Office's Myriad-Mayo...more

10/16/2014 - Biotechnology Guidance Update Mayo v. Prometheus Myriad-Mayo Patent-Eligible Subject Matter Patents Pharmaceutical Patents USPTO

USPTO Outlines Changes to Myriad-Mayo Guidance at BIO Symposium

Last Friday, at the Biotechnology Industry Organization (BIO) IP & Diagnostics Symposium in Alexandria, VA, the U.S. Patent and Trademark Office provided additional information regarding changes that the Office plans to make...more

10/1/2014 - AMP v Myriad Guidance Update Mayo v. Prometheus Myriad-Mayo Patent-Eligible Subject Matter Professional Conferences USPTO

Examination of Myriad-Mayo Guidance Comments -- International Bioindustry Associations

On March 4, the U.S. Patent and Trademark Office issued a guidance memorandum, entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural...more

8/12/2014 - Biotechnology Mayo v. Prometheus Myriad Myriad-Mayo Patent Litigation Patent-Eligible Subject Matter Patents Pharmaceutical Pharmaceutical Patents Public Comment Rulemaking Process USPTO

Examination of Myriad-Mayo Guidance Comments -- ACLU

On March 4, the U.S. Patent and Trademark Office issued a guidance memorandum entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural...more

8/6/2014 - ACLU Biotechnology Chemicals CLS Bank v Alice Corp Mayo v. Prometheus Memorandum of Guidance Myriad Myriad-Mayo Patent-Eligible Subject Matter Patents Pharmaceutical Public Comment Section 101 USPTO

USPTO Holds Forum on Subject Matter Eligibility -- Part IV

On May 9, the U.S. Patent and Trademark Office held a four-hour long forum to receive public feedback on the Myriad-Mayo Guidance, which was issued by the Office on March 4. According to the Office's Guidance webpage, the...more

7/10/2014 - AMP v Myriad Mayo v. Prometheus Patent-Eligible Subject Matter Patents SCOTUS USPTO

Docs @ BIO: USPTO Provides Update on Myriad-Mayo Guidance

At last week's BIO International Convention in San Diego, Andrew Hirshfeld, USPTO Deputy Commissioner for Patent Examination Policy, and June Cohan, a Legal Advisor with the USPTO's Office of Patent Legal Administration, took...more

7/2/2014 - DNA Genetic Materials Guidance Update Memorandum of Guidance Myriad Myriad-Mayo Patent-Eligible Subject Matter Patents Public Comment Section 101 Stem cells USPTO

USPTO Extends Deadline for Providing Feedback on Myriad-Mayo Guidance

As we reported earlier this week, the period for submitting written comments to the U.S. Patent and Trademark Office regarding the Office's Myriad-Mayo guidance memorandum has been extended to July 31, 2014. The Office...more

6/30/2014 - Memorandum of Guidance Myriad Myriad-Mayo Patent Trial and Appeal Board Patent-Eligible Subject Matter Patents USPTO

MBHB Snippets: Review of Developments in Intellectual Property Law - Volume 12, Issue 2 (Spring 2014)

In This Issue: - “Patent Trolls” in the Crosshairs – But How Will Patent Reform Legislation Impact the Rest of Us - USPTO Guidance Takes an Expansive View of Patent-Ineligible Subject Matter - Functional Claim...more

5/20/2014 - Data Protection Non-Practicing Entities Patent Exhaustion Patent Litigation Patent Reform Patent Trolls Patent-Eligible Subject Matter Trademarks USPTO

USPTO Holds Forum on Subject Matter Eligibility -- Part III

Last Friday, the U.S. Patent and Trademark Office held a four-hour long forum to receive public feedback on the Myriad-Mayo Guidance, which was issued by the Office on March 4. According to the Office's Guidance webpage, the...more

5/16/2014 - AMP v Myriad Mayo v. Prometheus Patent Applications Patent-Eligible Subject Matter Patents SCOTUS USPTO

USPTO Holds Forum on Subject Matter Eligibility -- Part II

Last Friday, the U.S. Patent and Trademark Office held a four-hour long forum to receive public feedback on the Myriad-Mayo Guidance, which was issued by the Office on March 4. According to the Office's Guidance webpage, the...more

5/15/2014 - Forum Myriad Patent Examinations Patent-Eligible Subject Matter Patents Public Comment SCOTUS USPTO

USPTO Holds Forum on Subject Matter Eligibility -- Part I

Last Friday, the U.S. Patent and Trademark Office held a four-hour long forum to receive public feedback on the Myriad-Mayo Guidance, which was issued by the Office on March 4. According to the Office's Guidance webpage, the...more

5/13/2014 - Guidance Update Myriad Patent Examinations Patent-Eligible Subject Matter Public Comment SCOTUS USPTO

USPTO Guidance Takes an Expansive View of Patent-Ineligible Subject Matter

On March 4, in a memorandum issued to the Patent Examining Corps by Deputy Commissioner for Patent Examination Policy Andrew Hirshfeld, the U.S. Patent and Trademark Office (“USPTO”) implemented a new procedure for...more

5/12/2014 - Patent Litigation Patent-Eligible Subject Matter Patents USPTO

39 Results
|
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×